OncoSec Medical Inc. | Balance Sheet

Fiscal year is August-July. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,970.20
37,852.70
32,035.30
28,746.20
11,444.70
26,978.10
Other Current Assets
199.50
466.50
1,532.70
671.20
1,068.90
1,643.70
Total Current Assets
5,169.70
38,319.20
33,568.00
29,417.40
12,513.60
28,621.80
Net Property, Plant & Equipment
151.60
581.10
1,808.00
2,799.90
2,410.10
1,265.70
Intangible Assets
1,161.70
464.70
-
-
-
-
Other Assets
26.70
26.70
214.10
189.30
309.20
359
Total Assets
6,509.70
39,391.60
35,590.10
32,406.60
15,232.90
30,246.50
Accounts Payable
729.10
-
-
-
1,537.90
Income Tax Payable
1.60
0.80
-
-
-
Other Current Liabilities
1,039.90
1,322.80
2,894.50
3,466.30
1,858.10
Total Current Liabilities
1,770.60
1,323.60
2,894.50
3,466.30
3,396.00
Other Liabilities
-
-
-
887.30
1,141.00
Total Liabilities
1,770.60
1,323.60
2,894.50
4,353.50
4,536.90
Common Equity (Total)
4,739.10
38,068.10
32,695.60
28,053.10
10,696.00
Total Shareholders' Equity
4,739.10
38,068.10
32,695.60
28,053.10
10,696.00
Total Equity
4,739.10
38,068.10
32,695.60
28,053.10
10,696.00
Liabilities & Shareholders' Equity
6,509.70
39,391.60
35,590.10
32,406.60
15,232.90

About OncoSec Medical

View Profile
Address
3565 General Atomics Court
San Diego California 92121
United States
Employees -
Website http://www.oncosec.com
Updated 07/08/2019
OncoSec Medical, Inc. engages in the design and commercialize medical products for the treatment of cancer. It involves in the discovery and development of novel immunotherapeutic products to improve treatment options for patients and physicians, which intends to treat oncology indications. The company was founded by Avtar S.